The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...

Oncology Small Molecule Drugs Market Expected to Grow Significantly Due to Industry Advancements. Growing Demand for Personalized Medicine and Target ...

This discovery, published in Nature, could greatly improve the fight against antibiotic-resistant superbugs. Structure of a proteasome molecule. The proteasome is present in all cells of the body. Its ...

How does that work? "Here’s a garbage can, proteasome," she shows a magnified example of a molecule. "Aaron Ciechanover and Avram Hershko, researchers at the Technion who won the Nobel Prize, ...

Rember® is a purified, proprietary formulation of methylthioninium chloride (MTC), also known as methylene blue. This old drug predates the FDA. It is being widely used in Africa to treat malaria, as ...

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed ... function of E3 ligases within the ubiquitin ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as Ozempic—in suppressing appetite and reducing body weight. Notably ...

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in suppressing appetite and reducing body weight. Notably ...